Close

Codexis (CDXS) Raises 2021 Guidance Following Receipt of Significant New Order for a Proprietary Enzyme

Go back to Codexis (CDXS) Raises 2021 Guidance Following Receipt of Significant New Order for a Proprietary Enzyme
CODEXIS (NASDAQ: CDXS) Delayed: 2.83 +0.03 (1.07%)
Previous Close $2.80    52 Week High $5.25 
Open $2.77    52 Week Low $2.93 
Day High $2.87    P/E N/A 
Day Low $2.71    EPS $-1.25 
Volume 465,339